中国计划生育和妇产科
中國計劃生育和婦產科
중국계화생육화부산과
CHINESE JOURNAL OF FAMILY PLANNING & GYNECOTOKOLOGY
2015年
2期
27-29,32
,共4页
子宫内膜异位症%促性腺激素释放激素激动剂%腹腔镜
子宮內膜異位癥%促性腺激素釋放激素激動劑%腹腔鏡
자궁내막이위증%촉성선격소석방격소격동제%복강경
endometriosis%gonadotropin-releasing hormone agonist%laparoscopy
目的:探讨腹腔镜微创手术联合促性腺激素释放激素激动剂( gonadotropin releasing hormone antagonist, GnRH-a)治疗中重度子宫内膜异位症(endometriosis,EMT)的临床疗效和安全性。方法分析2012年新泰市人民医院妇产科收治的82例中重度EMT患者临床资料,根据手术治疗前加用药物的不同分为GnRH-a组(28例)、口服避孕药组(28例)和单纯手术组(26例),比较3组患者术中、术后评价指标,疼痛症状视觉模拟评分( visual analogue scale , VAS),术后复发率和不良反应发生情况。结果 GnRH-a组较口服避孕药组和单纯手术组手术时间短、术中出血少、肛门排气和下床活动时间早(均P<0.05);随访12个月时,GnRH-a组VAS评分降低幅度明显高于其他两组,GnRH-a组复发率明显低于其他两组(均P<0.05)。 GnRH-a组低雌激素血症发生7例,患者均可以耐受,停止药物治疗后症状均消失;4个月内所有患者月经均恢复正常。结论腹腔镜微创手术联合GnRH-a术前治疗中重度EMT可有效提高手术效果、术后恢复快、复发率低,短期用药安全。
目的:探討腹腔鏡微創手術聯閤促性腺激素釋放激素激動劑( gonadotropin releasing hormone antagonist, GnRH-a)治療中重度子宮內膜異位癥(endometriosis,EMT)的臨床療效和安全性。方法分析2012年新泰市人民醫院婦產科收治的82例中重度EMT患者臨床資料,根據手術治療前加用藥物的不同分為GnRH-a組(28例)、口服避孕藥組(28例)和單純手術組(26例),比較3組患者術中、術後評價指標,疼痛癥狀視覺模擬評分( visual analogue scale , VAS),術後複髮率和不良反應髮生情況。結果 GnRH-a組較口服避孕藥組和單純手術組手術時間短、術中齣血少、肛門排氣和下床活動時間早(均P<0.05);隨訪12箇月時,GnRH-a組VAS評分降低幅度明顯高于其他兩組,GnRH-a組複髮率明顯低于其他兩組(均P<0.05)。 GnRH-a組低雌激素血癥髮生7例,患者均可以耐受,停止藥物治療後癥狀均消失;4箇月內所有患者月經均恢複正常。結論腹腔鏡微創手術聯閤GnRH-a術前治療中重度EMT可有效提高手術效果、術後恢複快、複髮率低,短期用藥安全。
목적:탐토복강경미창수술연합촉성선격소석방격소격동제( gonadotropin releasing hormone antagonist, GnRH-a)치료중중도자궁내막이위증(endometriosis,EMT)적림상료효화안전성。방법분석2012년신태시인민의원부산과수치적82례중중도EMT환자림상자료,근거수술치료전가용약물적불동분위GnRH-a조(28례)、구복피잉약조(28례)화단순수술조(26례),비교3조환자술중、술후평개지표,동통증상시각모의평분( visual analogue scale , VAS),술후복발솔화불량반응발생정황。결과 GnRH-a조교구복피잉약조화단순수술조수술시간단、술중출혈소、항문배기화하상활동시간조(균P<0.05);수방12개월시,GnRH-a조VAS평분강저폭도명현고우기타량조,GnRH-a조복발솔명현저우기타량조(균P<0.05)。 GnRH-a조저자격소혈증발생7례,환자균가이내수,정지약물치료후증상균소실;4개월내소유환자월경균회복정상。결론복강경미창수술연합GnRH-a술전치료중중도EMT가유효제고수술효과、술후회복쾌、복발솔저,단기용약안전。
Objective To investigate the efficacy and safety of laparoscope surgery combined with gonadotropin -releasing hormone agonist ( GnRH-a) in the treatment of moderate or severe endometriosis .Methods Data of 82 patients with moderate to severe endometriosis in Xintai City People’ s Hospital from Jan to Dec.2012 were collected, all cases were divided into GnRH -a group (28 cases), oral contraceptive group (28 cases) and surgery group (26 cases) according to medication treatment before surgery.The indicators of preoperative and postoperative evaluation , pain visual analogue scale ( VAS) , recurrence rate and adverse reaction were compared among the three groups .Results The operative time, the amount of blood loss in GnRH -a group were lower than in those in the other two groups .The activity time and anal exhaust time in GnRH -a group were earlier than those in the other two groups(P<0.05).After 12 months followed-up, the reduction of VAS in GnRH -a group was significantly higher than those in the other two groups .The recurrence rate in GnRH-a group was significantly lower than that in the other two groups (P<0.05).7 patients with low estrogen hyperlipidemia occurred in GnRH -a group, the adverse effects could be tolerated .The symptoms were disappeared when medication treatment stopped .Normal menstruation retrieved for all patients after 4 months.Conclusion The laparoscopic surgery combined with preoperative GnRH -a in treatment of moderate to severe endometriosis can effectively improve surgical effects , which has advantages of fast postoperative recovery , low recurrence rate and safe .